Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-18-000304
Filing Date
2018-03-29
Accepted
2018-03-29 17:24:28
Documents
2
Group Members
ORBIMED CAPITAL GP V LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 ss86017_sc13da.htm SC 13D/A 109730
2 JOINT FILING AGREEMENT ss86017_ex9901.htm EX-99.1 22455
  Complete submission text file 0000947871-18-000304.txt   133871
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Subject) CIK: 0001621227 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88833 | Film No.: 18724039
SIC: 2836 Biological Products, (No Diagnostic Substances)